HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 494 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $218,075 | -23.5% | 1,885 | -31.9% | 0.00% | – |
| Q2 2023 | $284,895 | -63.9% | 2,770 | -61.7% | 0.00% | -100.0% |
| Q1 2023 | $790,065 | -89.9% | 7,239 | -89.4% | 0.00% | -92.9% |
| Q4 2022 | $7,802,128 | +46.0% | 68,560 | -20.6% | 0.01% | +40.0% |
| Q3 2022 | $5,345,000 | -19.0% | 86,365 | +4.4% | 0.01% | -16.7% |
| Q2 2022 | $6,600,000 | -33.6% | 82,757 | -12.4% | 0.01% | -25.0% |
| Q1 2022 | $9,941,000 | +3.4% | 94,489 | +5.9% | 0.02% | +6.7% |
| Q4 2021 | $9,617,000 | +0.7% | 89,248 | +2.4% | 0.02% | -6.2% |
| Q3 2021 | $9,547,000 | +20.6% | 87,162 | +3.1% | 0.02% | +23.1% |
| Q2 2021 | $7,915,000 | +7.7% | 84,527 | +5.8% | 0.01% | 0.0% |
| Q1 2021 | $7,352,000 | +102.8% | 79,891 | +61.2% | 0.01% | +85.7% |
| Q4 2020 | $3,626,000 | +327.6% | 49,563 | +353.7% | 0.01% | +250.0% |
| Q3 2020 | $848,000 | +7.1% | 10,925 | -23.4% | 0.00% | 0.0% |
| Q2 2020 | $792,000 | +159.7% | 14,268 | +38.2% | 0.00% | +100.0% |
| Q1 2020 | $305,000 | -16.7% | 10,324 | +1.9% | 0.00% | 0.0% |
| Q4 2019 | $366,000 | – | 10,129 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |